Insider · CIK 0001246441

PANDYA HEMANSHU N

Reports to the SEC for 1 company · S. PLAINFIELD, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001246441

Forms 4 and 5

Insider transactions

25 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2004-12-01	ABLE LABORATORIES INCS Sale	V.P. Corporate Strategy	SSale	−1,000 sh	$21.63	−$21.6K	1,466
2004-12-01	ABLE LABORATORIES INCStock Option (right to buy)M Exercise/Conversion	V.P. Corporate Strategy	MExercise/Conversion	−1,000 sh	—	—	48,500
2004-12-01	ABLE LABORATORIES INCM Exercise/Conversion	V.P. Corporate Strategy	MExercise/Conversion	+1,000 sh	$4.00	+$4,000	2,466
2004-09-01	ABLE LABORATORIES INCS Sale	V.P. Corporate Strategy	SSale	+1,000 sh	$21.73	+$21.7K	1,466
2004-09-01	ABLE LABORATORIES INCStock Option (right to buy)M Exercise/Conversion	V.P. Corporate Strategy	MExercise/Conversion	−1,000 sh	—	—	49,500
2004-09-01	ABLE LABORATORIES INCM Exercise/Conversion	V.P. Corporate Strategy	MExercise/Conversion	+1,000 sh	$4.00	+$4,000	2,466
2003-12-01	ABLE LABORATORIES INCS Sale	V.P. Corporate Strategy	SSale	−2,500 sh	$18.61	−$46.5K	1,466
2003-12-01	ABLE LABORATORIES INCStock Option (right to buy)M Exercise/Conversion	V.P. Corporate Strategy	MExercise/Conversion	−2,500 sh	$4.00	−$10K	62,500
2003-12-01	ABLE LABORATORIES INCM Exercise/Conversion	V.P. Corporate Strategy	MExercise/Conversion	+2,500 sh	$4.00	+$10K	3,966
2003-10-02	ABLE LABORATORIES INCM Exercise/Conversion	V.P. Corporate Strategy	MExercise/Conversion	+2,500 sh	$4.00	+$10K	3,966
2003-10-02	ABLE LABORATORIES INCS Sale	V.P. Corporate Strategy	SSale	−2,500 sh	$18.24	−$45.6K	1,466
2003-10-02	ABLE LABORATORIES INCStock Option (right to buy)M Exercise/Conversion	V.P. Corporate Strategy	MExercise/Conversion	−2,500 sh	$4.00	−$10K	65,000
2003-08-08	ABLE LABORATORIES INCS Sale	V.P. Corporate Strategy	SSale	−130 sh	$22.10	−$2,873	1,650
2003-08-08	ABLE LABORATORIES INCS Sale	V.P. Corporate Strategy	SSale	−86 sh	$22.00	−$1,892	1,780
2003-08-08	ABLE LABORATORIES INCS Sale	V.P. Corporate Strategy	SSale	−130 sh	$22.05	−$2,866.5	1,866
2003-08-08	ABLE LABORATORIES INCS Sale	V.P. Corporate Strategy	SSale	−184 sh	$22.17	−$4,079.28	1,466
2003-08-08	ABLE LABORATORIES INCS Sale	V.P. Corporate Strategy	SSale	−107 sh	$21.55	−$2,305.85	1,996
2003-08-07	ABLE LABORATORIES INCS Sale	V.P. Corporate Strategy	SSale	−220 sh	$21.20	−$4,664	2,982
2003-08-07	ABLE LABORATORIES INCS Sale	V.P. Corporate Strategy	SSale	−219 sh	$21.30	−$4,664.7	2,323
2003-08-07	ABLE LABORATORIES INCS Sale	V.P. Corporate Strategy	SSale	−220 sh	$21.35	−$4,697	2,103
2003-08-07	ABLE LABORATORIES INCS Sale	V.P. Corporate Strategy	SSale	−440 sh	$21.25	−$9,350	2,542
2003-08-06	ABLE LABORATORIES INCStock Option (right to buy)M Exercise/Conversion	V.P. Corporate Strategy	MExercise/Conversion	−2,500 sh	$4.00	−$10K	67,500
2003-08-06	ABLE LABORATORIES INCM Exercise/Conversion	V.P. Corporate Strategy	MExercise/Conversion	+2,500 sh	$4.00	+$10K	3,966
2003-08-06	ABLE LABORATORIES INCS Sale	V.P. Corporate Strategy	SSale	−437 sh	$22.25	−$9,723.25	3,529
2003-08-06	ABLE LABORATORIES INCS Sale	V.P. Corporate Strategy	SSale	−327 sh	$21.70	−$7,095.9	3,202

Recent filings

Accepted (ET)
Dec 34
ABLE LABORATORIES INC0001072613-04-002277
SEC(opens sec.gov)
Sep 34
PANDYA HEMANSHU N0001072613-04-001646
SEC(opens sec.gov)
Dec 34
PANDYA HEMANSHU N0001072613-03-001952
SEC(opens sec.gov)
Oct 64
PANDYA HEMANSHU N0001072613-03-001608
SEC(opens sec.gov)
Aug 124
PANDYA HEMANSHU N0001072613-03-001342
SEC(opens sec.gov)
Aug 84
PANDYA HEMANSHU N0001072613-03-001312
SEC(opens sec.gov)

Companies

ABLE LABORATORIES INCV.P. Corporate Strategy

Address

ABLE LABORATORIES INC 6 HOLLYWOOD CT.

S. PLAINFIELD, NJ, 07080